- Zhao, Xinyi;
- Zeng, Wen;
- Xu, Hong;
- Sun, Zihan;
- Hu, Yingxin;
- Peng, Beibei;
- McBride, Jennifer;
- Duan, Jiangtao;
- Deng, Juan;
- Zhang, Bin;
- Kim, Soo-Jung;
- Zoll, Bryan;
- Saito, Takashi;
- Sasaguri, Hiroki;
- Saido, Takaomi;
- Yao, Haishan;
- Wang, Zhaoyin;
- Trojanowski, John;
- Brunden, Kurt;
- Lee, Virginia;
- He, Zhuohao;
- Ballatore, Carlo
Tau pathogenesis is a hallmark of many neurodegenerative diseases, including Alzheimers disease (AD). Although the events leading to initial tau misfolding and subsequent tau spreading in patient brains are largely unknown, traumatic brain injury (TBI) may be a risk factor for tau-mediated neurodegeneration. Using a repetitive TBI (rTBI) paradigm, we report that rTBI induced somatic accumulation of phosphorylated and misfolded tau, as well as neurodegeneration across multiple brain areas in 7-month-old tau transgenic PS19 mice but not wild-type (WT) mice. rTBI accelerated somatic tau pathology in younger PS19 mice and WT mice only after inoculation with tau preformed fibrils and AD brain-derived pathological tau (AD-tau), respectively, suggesting that tau seeds are needed for rTBI-induced somatic tau pathology. rTBI further disrupted axonal microtubules and induced punctate tau and TAR DNA binding protein 43 (TDP-43) pathology in the optic tracts of WT mice. These changes in the optic tract were associated with a decline of visual function. Treatment with a brain-penetrant microtubule-stabilizing molecule reduced rTBI-induced tau, TDP-43 pathogenesis, and neurodegeneration in the optic tract as well as visual dysfunction. Treatment with the microtubule stabilizer also alleviated rTBI-induced tau pathology in the cortices of AD-tau-inoculated WT mice. These results indicate that rTBI facilitates abnormal microtubule organization, pathological tau formation, and neurodegeneration and suggest microtubule stabilization as a potential therapeutic avenue for TBI-induced neurodegeneration.